BACKGROUND: Many patients with amyotrophic lateral sclerosis (ALS) with cognitive impairment have fronto-temporal dysfunction. Whereas in some patients with ALS the fronto-temporal dysfunction is undoubtedly due to the degenerative process associated with the disease, in others dysfunction cannot be accounted for by an irreversible degenerative process alone, as it also appears to involve a reversible process. We hypothesised that reduced vital capacity can be a key contributor to the fronto-temporal dysfunction observed in patients with ALS. OBJECTIVE: To investigate the association between fronto-temporal dysfunction and reduced vital capacity in ALS. METHODS: 16 consecutive patients who conformed to a diagnosis of definite or probable ALS (El escorial criteria) were grouped by vital capacity, and their clinical characteristics and cognitive functions, including disease duration, attention, executive function and memory, were measured. RESULTS: Patients with a reduced vital capacity performed significantly poorer in memory retention (p = 0.028), retrieval efficacy (p = 0.003), spoken verbal fluency (p = 0.03) and spoken verbal fluency indexes (p = 0.016) than those with a normal vital capacity. CONCLUSION: The fronto-temporal dysfunction in ALS might be attributable to potentially reversible secondary effects associated with reduced vital capacity, as well as to the primary degenerative process.
BACKGROUND: Many patients with amyotrophic lateral sclerosis (ALS) with cognitive impairment have fronto-temporal dysfunction. Whereas in some patients with ALS the fronto-temporal dysfunction is undoubtedly due to the degenerative process associated with the disease, in others dysfunction cannot be accounted for by an irreversible degenerative process alone, as it also appears to involve a reversible process. We hypothesised that reduced vital capacity can be a key contributor to the fronto-temporal dysfunction observed in patients with ALS. OBJECTIVE: To investigate the association between fronto-temporal dysfunction and reduced vital capacity in ALS. METHODS: 16 consecutive patients who conformed to a diagnosis of definite or probable ALS (El escorial criteria) were grouped by vital capacity, and their clinical characteristics and cognitive functions, including disease duration, attention, executive function and memory, were measured. RESULTS:Patients with a reduced vital capacity performed significantly poorer in memory retention (p = 0.028), retrieval efficacy (p = 0.003), spoken verbal fluency (p = 0.03) and spoken verbal fluency indexes (p = 0.016) than those with a normal vital capacity. CONCLUSION: The fronto-temporal dysfunction in ALS might be attributable to potentially reversible secondary effects associated with reduced vital capacity, as well as to the primary degenerative process.
Authors: Stuart F Quan; Ron Wright; Carol M Baldwin; Kristine L Kaemingk; James L Goodwin; Tracy F Kuo; Alfred Kaszniak; Lori L Boland; Elise Caccappolo; Richard R Bootzin Journal: Sleep Med Date: 2006-07-03 Impact factor: 3.492
Authors: S Shellikeri; V Karthikeyan; R Martino; S E Black; L Zinman; J Keith; Y Yunusova Journal: Neurosci Biobehav Rev Date: 2017-02-02 Impact factor: 8.989
Authors: Marta Pinto-Grau; Bronagh Donohoe; Sarah O'Connor; Lisa Murphy; Emmet Costello; Mark Heverin; Alice Vajda; Orla Hardiman; Niall Pender Journal: Neurol Clin Pract Date: 2021-10
Authors: Jennifer Murphy; Pam Factor-Litvak; Raymond Goetz; Catherine Lomen-Hoerth; Peter L Nagy; Jonathan Hupf; Jessica Singleton; Susan Woolley; Howard Andrews; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Boguslawa A Koczon-Jaremko; Hiroshi Mitsumoto Journal: Neurology Date: 2016-01-22 Impact factor: 9.910
Authors: Laura Jelsone-Swain; Carol Persad; Kristen L Votruba; Sara L Weisenbach; Timothy Johnson; Kirsten L Gruis; Robert C Welsh Journal: Front Psychol Date: 2012-12-17
Authors: Adriana M Strutt; Jennette Palcic; John G Wager; Courtney Titus; Claire Macadam; Jeffrey Brown; Bonnie M Scott; Yadollah Harati; Paul E Schulz; Michele K York Journal: ISRN Neurol Date: 2012-07-17